App
Moneycontrol App Android App iOS App iPad App Android Tab Blackberry Windows App Windows Tab
Subscription
Specials
Stocks
Feedback
Log In
Sign Up
Moneycontrol Be a Pro
Get App
Select Language
Subscription
Specials
Close Ad
SENSEX NIFTY
you are here:

Markets

Live TV
NIFTY 50
11999.10
59.00 (0.49%)
SENSEX
40651.64
181.94 (0.45%)

Beryl Drugs Ltd.

BSE: 524606 | NSE: | ISIN: INE415H01017 | SECTOR: Pharmaceuticals

Success
Alert
Please select a Day.
Info
Moneycontrol Pro TTrade Now Thomson Reuters report
| BSE 4.89 -0.21 (-4.12%) | |

BSE Live

Nov 19, 15:33
4.89 -0.21 (-4.12%)
Volume
AVERAGE VOLUME
5-Day
1,246
10-Day
1,057
30-Day
1,026
342

  • Prev. Close

    5.10

  • Open Price

    5.34

4.89

Today’s L/H

5.34
3.59

52 Wk L/H

11.00
4.85

L/U Price Band

5.35

  • Bid Price (Qty.)

    0.00 (0)

  • Offer Price (Qty.)

    0.00 (0)

  •  VWAP
    5.18

  • Market Depth (19 Nov 2019)

    BUYSELL
    QTY PRICE PRICE QTY
    50 4.65 4.89 25
    0 0.00 5.13 200
    0 0.00 0.00 0
    0 0.00 0.00 0
    0 0.00 0.00 0
    0 Total Total 0
     Market Depth
    BUY 0
    SELL 0
    0%
    0%

NSE Live

(%)
Volume
No Data Available

  • Prev. Close

  • Open Price

Today’s L/H

52 Wk L/H

L/U Price Band

  • Bid Price (Qty.)

    ()

  • Offer Price (Qty.)

    ()

  • VWAP
    Series:
  • DELIVERY AVERAGES
    3-Day
    %
    5-Day
    %
    8-Day
    %
    Deliverables
    %
  • SMA
Beryl Drugs is not listed on NSE

Charts

  • Open : -
  • High : -
  • Low -
  • Close: -
  • Volume -

Valuation

    • Market Cap (Rs Cr.)
      2.48
    • P/E
      3.24
    • Book Value (Rs)
      14.80
    • Dividend (%)
      0.00
    • Market Lot
      1
    • Industry P/E
      29.06
    • EPS (TTM)
      1.51
    • P/C
      2.29
    • Price/Book
      0.33
    • Dividend Yield.(%)
      -
    • Face Value (RS)
      10.00
    • Deliverables (%)
      -

* Note - P.E (TTM) is displayed only when latest 4 quarter results are positive.

    • Market Cap (Rs Cr.)
      2.48
    • P/E
      1.59
    • Book Value (Rs)
      11.96
    • Dividend (%)
      0.00
    • Market Lot
      1
    • Industry P/E
      29.06
    • EPS (TTM)
      3.07
    • P/C
      1.31
    • Price/Book
      0.41
    • Dividend Yield.(%)
      -
    • Face Value (RS)
      10.00
    • Deliverables (%)
      -

* Note - P.E (TTM) is displayed only when latest 4 quarter results are positive.

Simple Moving Averages
DAYS BSE NSE
Get Historical Stock Prices
Click here to view the Open, High, Low, Close, Volume and Spread data.

Forum

Community Sentiments

Data not Available

What's your call on today?

Read 0 investor views

BUY SELL HOLD
POST

Action in Beryl Drugs Ltd.

  • 52 Week Low

    Beryl Drugs has hit 52wk low of Rs 4.30 on BSE

    Aug 26, 15:30

  • Technicals

    Beryl Drugs closes above 30-Day Moving Average of 9.90 today.

    Dec 14

  • Only Sellers

    Only Sellers in Beryl Drugs on BSE

    Jun 13, 14:15

  • Only Buyers

    Only Buyers in Beryl Drugs on BSE

    Jun 11, 15:05

  • Only Buyers

    Only Buyers in Beryl Drugs on BSE

    Jun 07, 11:25

  • Only Buyers

    Only Buyers in Beryl Drugs on BSE

    May 31, 10:05

  • Only Buyers

    Only Buyers in Beryl Drugs on BSE

    Feb 15, 10:40

  • Only Buyers

    Only Buyers in Beryl Drugs on BSE

    Feb 14, 11:35

  • Only Buyers

    Only Buyers in Beryl Drugs on BSE

    Feb 12, 10:55

  • Announcements

    Beryl Drugs' board meeting on February 09, 2018

    Feb 02, 08:00
  • Only Buyers

    Only Buyers in Beryl Drugs on BSE

    Feb 01, 13:05

  • Only Sellers

    Only Sellers in Beryl Drugs on BSE

    Jan 23, 10:05

  • Only Buyers

    Only Buyers in Beryl Drugs on BSE

    Jan 18, 10:05

  • Only Buyers

    Only Buyers in Beryl Drugs on BSE

    Jan 17, 10:05

  • Only Buyers

    Only Buyers in Beryl Drugs on BSE

    Jan 16, 10:05

  • Only Buyers

    Only Buyers in Beryl Drugs on BSE

    Jan 15, 10:05

  • 52 Week Low

    Beryl Drugs has hit 52wk low of Rs 9.31 on BSE

    Jan 12, 09:16

  • 52 Week Low

    Beryl Drugs has hit 52wk low of Rs 9.31 on BSE

    Jan 11, 09:16

  • 52 Week Low

    Beryl Drugs has hit 52wk low of Rs 9.31 on BSE

    Jan 10, 09:16

  • 52 Week Low

    Beryl Drugs has hit 52wk low of Rs 9.31 on BSE

    Jan 09, 09:16

News & Videos

Beryl Drugs Standalone June 2019 Net Sales at Rs 4.23 crore, up 1.03% Y-o-Y

Beryl Drugs Standalone June 2019 Net Sales at Rs 4.23 crore, up 1.03% Y-o-Y

Business | Earnings | Management Interviews
View More

News across the web

Data not available
Data not available
Data not available

Announcements

View More

Pre-Opening Session Prices9:00 am - 9:15 am

BSE - No shares traded
NSE - No shares traded

Financials

Income Statement

  Sep 2019 Jun 2019 Mar 2019 Dec 2018 Sep 2018
Net Sales 3.27 4.23 2.25 3.06 3.51
Other Income -- -- 0.16 -- --
PBDIT 0.36 0.57 0.01 0.34 0.36
Net Profit 0.17 0.34 0.10 0.14 0.14
  Mar 2018 Dec 2017 Sep 2017 Jun 2017 Mar 2017
Net Sales 4.26 3.63 3.22 4.85 2.38
Other Income -- -- -- -- --
PBDIT 0.93 0.25 0.25 0.20 0.12
Net Profit 0.88 0.10 0.54 0.03 -0.02

Balance Sheet

Standalone Mar 2019 Mar 2018
Total Share Capital 5.09 5.09
Networth 7.52 6.66
Total Debt 1.97 1.46
Net Block 8.20 2.22
Investments 0.48 0.22
Total Assets 9.51 8.14

Historical Prices

On
 Current Price %Gain / Loss
No Record Found
On
 Current Price %Gain / Loss
No Record Found
Click Here to view the Open, High, Low, Close, Volume and Historic data for
Index Price Change %Chg
NIFTY 50 11999.10 59.00 0.49
SENSEX 40651.64 181.94 0.45
NIFTY BANK 31353.80 117.50 0.38
NIFTY IT 15318.50 13.60 0.09
S&P BSE Smallcap 13414.43 9.92 0.07
View More
Index Price Change %Chg
Nasdaq (Nov 21) 8,508.05 -62.61 -0.73
DAX (Nov 20) 13,158.14 -62.98 -0.48
FTSE (Nov 20) 7,262.49 -61.31 -0.84
CAC (Nov 20) 5,894.03 -15.02 -0.25
SGX Nifty (Nov 21) 12,013.50 1.50 0.01
View More

CORPORATE ACTION

Date Agenda
Nov 12, 2019 Quarterly Results
Aug 09, 2019 Quarterly Results
May 30, 2019 Audited Results & Others
Apr 24, 2019 Others
Feb 12, 2019 Quarterly Results
Type Dividend% Ex-Dividend date
Final 0.00 Aug 23, 2002
Ratio Announcement Date Ex-Bonus
No Bonus Information is available for Beryl Drugs
Old FV New FV Ex-Split
No Splits Information is available for Beryl Drugs
Ratio Premium Ex-Bonus
No Rights Information is available for Beryl Drugs
Date Agenda
- -
Sep 29, 2018 -
Aug 26, 2017 -
Aug 26, 2016 -
Sep 30, 2015 -

Dividend Summary

The company has a good dividend track report and has consistently declared dividends for the last 5 years.

SHARE HOLDING PATTERN & MUTUAL FUND HOLDING

Share Holding Pattern in (%)

Standalone March 2019 December 2018 September 2018 June 2018
Promoters 24.92 24.92 24.92 24.92
Pledged 0 0 0 0
FII/FPI 0 0 0 0
Total DII 6.42 6.53 6.56 6.74
Fin.Insts 0 0 0 0
Insurance Co 0 0 0 0
MF 0 0 0 0
Others DIIs 6.42 6.53 6.56 6.74
Others 68.66 68.55 68.52 68.33
Total 100 100 100 99.99

Mutual Funds Holding

Data not available

PEERS COMPARISON

Company Name Last Price % Change 52 Wk High 52 Wk Low Market Cap Sales Qtr Net Profit Qtr
Beryl Drugs 4.89 0.00 11.00 3.59 2.48 13.20 0.59
Sun Pharma 450.20 5.73 616.50 350.40 108018.06 10,303.21 816.60
Dr Reddys Labs 2837.65 3.36 2965.20 2065.30 47146.35 10,625.50 1,277.30
Divis Labs 1763.30 1.77 1797.00 1214.25 46810.07 4,879.66 1,332.65
Cipla 482.65 2.31 645.00 389.55 38906.74 12,374.01 1,888.41

COMPANY OVERVIEW

Beryl Drugs Ltd is into manufacturing and marketing of branded, generic pharmaceutical formulations. The company is one of the leading manufacturer of I.V.fluids and small volume injectables.They own brands like BERI-CEF injection, F-Neuron, Amplicillin INJ, P-Mol, Biprox, B-Flox and many more.Products manufactured by the company include Small volume injectables in liquid form,Small volume injectables in dry powder form, Variety of eye and ear drops,I.V.Fluids in polypack and glass bottles and Variety of vetrinary medicines

COMPANY INFORMATION

  • Registered Office

  • Registrars

  • Management

    • Name

      Designation

    • Sudhir Sethi

      Chairman & Director

    • Sanjay Sethi

      Managing Director

    • Shreya Saraf

      Independent Director

    • Abhinav Naik

      Independent Director

    • Shreya Saraf

      Independent Director

  • Listing

    Whether The Company Forms A Part Of The Following Indices -
    • Sensex

      No

    • Nifty

      No

    • Bse-100

      No

    • Bse-200

      No

    • S&P CNX 500

      No

    • CNX Midcap

      No

About Beryl Drugs Ltd.

Beryl Drugs is in the Pharmaceuticals sector.

It is listed on the BSE with a BSE Code of 524606.

Quick links

News

Corporate Action

Information

Financials

Annual Report

Peer Comparison

Related Searches

Beryl Drugs Stock Price | Beryl Drugs Stock Quote | Beryl Drugs Results | Beryl Drugs News | View All Related Searches
Sections
Desktop Version »
Follow us on
Available On
Disclaimer | Terms & Conditions | Privacy Policy | Cookie Policy | FAQs | Sitemap | Feedback
Network 18 Sites: News18 | Firstpost | CNBC TV18 | In.com | Cricketnext | Overdrive | Topper Learning

Copyright © e-Eighteen.com Ltd All rights resderved. Reproduction of news articles, photos, videos or any other content in whole or in part in any form or medium without express writtern permission of moneycontrol.com is prohibited.